SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-103175
Filing Date
2023-09-22
Accepted
2023-09-22 16:02:52
Documents
14
Period of Report
2023-09-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2326688d1_8k.htm   iXBRL 8-K 29972
2 EXHIBIT 10.1 tm2326688d1_ex10-1.htm EX-10.1 215484
3 EXHIBIT 99.1 tm2326688d1_ex99-1.htm EX-99.1 8960
  Complete submission text file 0001104659-23-103175.txt   485177

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA rsls-20230919.xsd EX-101.SCH 3048
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE rsls-20230919_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rsls-20230919_pre.xml EX-101.PRE 22381
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2326688d1_8k_htm.xml XML 3220
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 949-429-6680
ReShape Lifesciences Inc. (Filer) CIK: 0001427570 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37897 | Film No.: 231271698
SIC: 3841 Surgical & Medical Instruments & Apparatus